Concepedia

Heather Wescott

HW

Statistics

Publications

5

Citations

166

H-Index

5

Active since

2017

Affiliations

Infectious Disease Research Institute(Current)

Eli Lilly (United States)

Heather Wescott is an author at Infectious Disease Research Institute specializing in tuberculosis, drug discovery, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2017–2024

5

Publications

5

Identification of Morpholino Thiophenes as Novel <i>Mycobacterium tuberculosis</i> Inhibitors, Targeting QcrB

Laura A. T. Cleghorn, Peter C. Ray, Joshua Odingo et al. · Journal of Medicinal Chemistry · 2018 · 56 citations · Full text

, , +20

Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels

Theresa O’Malley, Torey Alling, Julie V. Early et al. · Antimicrobial Agents and Chemotherapy · 2018 · 54 citations · Full text

Imidazoles Induce Reactive Oxygen Species in <i>Mycobacterium tuberculosis</i> Which Is Not Associated with Cell Death

Heather Wescott, David M. Roberts, Christian L. Allebach et al. · ACS Omega · 2017 · 29 citations · Full text

Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis

Heather Wescott, Edison S. Zuniga, Anumita Bajpai et al. · Frontiers in Microbiology · 2018 · 14 citations · Full text

Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency

Pamela J. Smolak, MyTrang Nguyen, Christine Diamond et al. · Journal of Pharmacology and Experimental Therapeutics · 2024 · 13 citations · Full text

1–5 of 5